STARTON THERAPEUTICS
Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies.
STARTON THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.startontx.com
Total Employee:
11+
Status:
Active
Contact:
+1 800 449 5405
Total Funding:
8.53 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Current Employees Featured
Pedro Lichtinger Chairman & CEO @ Starton Therapeutics
Chairman & CEO
2017-03-01
Founder
Official Site Inspections
http://www.startontx.com Semrush global rank: 9.05 M Semrush visits lastest month: 445
- Host name: ec2-18-168-176-179.eu-west-2.compute.amazonaws.com
- IP address: 18.168.176.179
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Startontx.com lookup results from whois.cloudflare.com server:
- Domain created: 3rd-Dec-2019
- Domain updated: 18th-Jul-2024
- Domain expires: 3rd-Dec-2026 1 Year, 235 Days left
- Website age: 5 Years, 129 Days
- Registrar Domain ID: 2463125142_DOMAIN_COM-VRSN
- Registrar Url: http://www.cloudflare.com
- Registrar WHOIS Server: whois.cloudflare.com
- Registrar Abuse Contact Email: registrar-abuse@cloudflare.com
- Registrar Abuse Contact Phone: +1.6503198930
- Name server:
- EVANGELINE.NS.CLOUDFLARE.COM
- STANLEY.NS.CLOUDFLARE.COM
More informations about "Starton Therapeutics"
About - Starton Therapeutics
Overcoming the limits of standard of care therapies. Starton is a clinical-stage biotechnology company transforming standard-of-care therapies with its proprietary continuous delivery technology platform, so people with cancer …See details»
Starton Therapeutics Contracts Global Clinical Research …
Jul 10, 2023 Paramus, NJ – Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 …
PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as
Sep 24, 2024 “As someone who has dedicated his career towards advancing new treatments for cancer, I am inspired by the Foundation’s success in expanding patient access to potentially …See details»
Starton Therapeutics - Crunchbase Company Profile & Funding
Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to …See details»
Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to …
Apr 27, 2023 To learn more, visit startontx.com. About Healthwell Healthwell is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, …See details»
Starton Therapeutics’ Chief Executive Officer ... - Markets Insider
Sep 24, 2024 “As someone who has dedicated his career towards advancing new treatments for cancer, I am inspired by the Foundation’s success in expanding patient access to potentially …See details»
Starton Therapeutics Company Overview, Contact Details
Oct 11, 2023 Startontx hired Moses Dodo as Board of Directors on Sep 27th '22. Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company …See details»
Starton Therapeutics - VentureRadar
"A clinical-stage biotechnology company focused on transforming standard of care therapeutics. Starton uses proven continuous delivery technology to obtain new indications or develop on …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as ... - BioSpace
PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 …
PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»
Starton Therapeutics Announces Approval to Proceed with Final …
May 23, 2022 Starton Therapeutics, Inc. Independent safety review approved dose escalation and initiation of third and final dosing cohort. STAR-LLD well tolerated in all subjects dosed to …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 …
Sep 24, 2024 PARAMUS, N.J., – Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary …See details»
Starton Therapeutics Announces STARTICLES Filing - GlobeNewswire
Jan 17, 2024 To learn more, visit www.startontx.com. Forward looking statements. This press release contains statements that constitute “forward-looking statements.” Forward-looking …See details»
Starton Therapeutics, Inc. (Starton Therapeutics, Inc.) - 药物管线_ …
To learn more, visit www.startontx.com. Forward Looking Statements All statements other than statements of historical facts included in this press release, including, without limitation, …See details»
Starton Therapeutics - Overview, News & Similar companies
U.S. Patent and Trademark Office Grants US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine” PARAMUS, N.J., May 20, 2024 (GLOBE …See details»
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 …
PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) — Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»
Pete & Thomas Foundation: Megan Thee Stallion’s nonprofit helps …
1 day ago The artist founded the Pete and Thomas Foundation in 2022,which is a nonprofit organization to honor her mother Holly Thomas and father Joseph Pete Jr. ...See details»
Starton Therapeutics Announces the Opening of the First Clinical …
Sep 13, 2023 Paramus, NJ – Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with …See details»
Press Releases - Starton Therapeutics
Feb 14, 2024 Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma. June 12, 2023. Starton Therapeutics …See details»